Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

NIP-565: a JAK-1 inhibitor for rheumatoid arthritis

Nov. 16, 2015

Abeta42-targeting MAb MEDI-1814 well tolerated in patients with Alzheimer's disease

Nov. 16, 2015

Preclinical data on TBI-302 that led to advancement into phase I for HCC

Nov. 16, 2015

Daiichi Sankyo presents preclinical and phase I results for DS-3032b

Nov. 16, 2015

Early clinical data for Macrogenics' MGA-271

Nov. 16, 2015

Researchers at CSIC present alpha-synuclein overexpressing mouse model

Nov. 16, 2015

HiQ-0013 identified as promising candidate for cognitive deficits

Nov. 13, 2015

Clinical and preclinical data presented for Incyte's IDO inhibitor epacadostat

Nov. 13, 2015

NFKB1 identified as a biomarker for severe malarial anemia in pediatric patients

Nov. 13, 2015

Novel inhibitors block LIM kinase activity in cancer cell lines

Nov. 12, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...